The Effect of Semi-recumbent Position on Hypoxemia After Lung Segment/Lobe Surgery
1 other identifier
observational
308
1 country
1
Brief Summary
Thoracoscopic surgery is the most common surgical approach in thoracic surgery, which reduces surgical trauma and postoperative pain compared with open thoracotomy, but postoperative complications should not be overlooked, with hypoxemia being particularly prominent. Postoperative hypoxemia is highly prevalent among patients recovering from non-cardiac surgery, accounting for over one-third of all cases. Hypoxemia impairs wound healing and leads to other severe complications such as cerebral dysfunction, arrhythmia, and myocardial ischemia, all of which adversely affect postoperative recovery. Although oxygen therapy can prevent and treat hypoxemia, many patients still experience hypoxia in the post-anesthesia care unit (PACU). Numerous studies have investigated various ventilation techniques aimed at enhancing postoperative pulmonary function, but the benefits of protective ventilation strategies may be lost during emergence from anesthesia. Several other studies also indicate that intraoperative ventilation measures do not improve postoperative pulmonary function. The lack of evidence demonstrating the efficacy of oxygen therapy or protective ventilation techniques in treating postoperative hypoxemia underscores the need to explore alternative strategies. Patient positioning during emergence from anesthesia is associated with perioperative and postoperative complications. Although no consensus exists on the optimal patient position during emergence, the supine position is often favored by anesthesiologists due to its simplicity and ease of monitoring. However, the reduced functional residual capacity associated with the supine position tends to promote airway closure and diminish gas exchange.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 23, 2024
CompletedFirst Submitted
Initial submission to the registry
June 23, 2025
CompletedFirst Posted
Study publicly available on registry
July 11, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 22, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2026
ExpectedJuly 11, 2025
December 1, 2024
12 months
June 23, 2025
July 1, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Incidence of post-PACU hypoxemia
defined as SpO2 \<90% for less than 60 seconds
Perioperative
Secondary Outcomes (9)
The incidence of severe hypoxemia
Perioperative
the time of the first episode of hypoxemia
Perioperative
Airway first aid
Perioperative
Breathing comfort
Perioperative
Wound pain VAS score
measured and recorded at rest and cough, 5 and 30 minutes after extubation, before leaving PACU and 24,48 and 72 hours postoperative
- +4 more secondary outcomes
Other Outcomes (4)
Adverse events related to position
Perioperative
15-item recovery quality scale (Quality of Recovery-15, QoR-15) scores
at 1 and 3 days postoperative
Postoperative inflammatory markers
On the first day after surgery
- +1 more other outcomes
Study Arms (2)
Exposure group
Semi-recumbent position during anesthesia recovery
Non exposed group
Supine position during anesthesia recovery
Interventions
During anesthesia recovery, the patient's position should be in a semi-recumbent position
Eligibility Criteria
Patients undergoing thoracoscopic lobectomy and segmental resection
You may qualify if:
- Age 18-85 years old; Undergo thoracoscopic segment/lobectomy; American Society of Anesthesiologists (ASA) grade 1\~3
You may not qualify if:
- Patients with mental or cognitive dysfunction who cannot communicate normally; Patients with tracheal catheters retained in ICU; Patients with cervical spondylosis, ankylosing spondylitis and other patients who cannot lift their upper body; Patients who have participated in other clinical trials; Patients who refuse to sign informed consent; Patients who have had chest surgery in the past.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Shanghai Pulmonary Hospital
Shanghai, Shanghai Municipality, 200090, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Yang Hao, postdoctor
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 308 Days
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- post-doctoral
Study Record Dates
First Submitted
June 23, 2025
First Posted
July 11, 2025
Study Start
December 23, 2024
Primary Completion
December 22, 2025
Study Completion (Estimated)
September 30, 2026
Last Updated
July 11, 2025
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share